ANOVA BLCA result package
Francesco Iorio, EMBL - European Bioinformatics Institute
result parsing started on 2016-04-08 10:28:13 iorio@ebi.ac.uk
Drug Domain: GDSC1000_paper_set, Analysis Domain: BLCA specific
Individual drug analysis: 135
Drug details and screening numbers
Drug Name: Gemcitabine
Drug ID: 135
Synonyms: LY-188011
Brand name: Gemzar
Target: DNA replication
Number of cell lines screened: 870
Screening concentration range(s): 0.004 to 1.024 uM
Statistically significant associations identified = 1
association id |
FEATURE |
Drug id |
Propr |
Public |
Drug Name |
Drug Target |
N FEATURE pos |
N FEATURE neg |
log max Conc tested |
FEATURE neg logIC50 MEAN |
FEATURE pos logIC50 MEAN |
FEATURE deltaMEAN IC50 |
FEATURE IC50 effectSize |
FEATURE neg Glass delta |
FEATURE pos Glass delta |
ANOVA FEATURE pval |
Tissue ANOVA pval |
MSI ANOVA pval |
ANOVA FEATURE FDR % |
a6 |
TP53_mut |
135 |
1 |
1 |
Gemcitabine |
DNA replication |
15 |
4 |
0.0237 |
1.46 |
-3.36 |
-4.82 |
2.3 ** |
3.5 ** |
2.2 ** |
7.27e-04 |
NA |
NA |
24 |
All-tests volcano plot